Pancreatic Elastase Testing Market Size

Pancreatic Elastase Testing Market size was valued at USD 16.28 billion in 2023 and is likely to reach USD 43.22 billion by the end of 2036, expanding at around 7.8% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of pancreatic elastase testing is assessed at USD 17.3 billion.

Pancreatic elastase test, also known as, fecal elastase, is used to test the amount of elastase produced in the body. Elastase is an enzyme secreted by the pancreas to break down fats, proteins, and carbohydrates. The growth of the market can be attributed to the increasing prevalence of pancreatic insufficiency, chronic pancreatitis, and others. According to a report published by National Center for Biotechnology Information and StatPearls Publishing, chronic pancreatitis occurs in 42 to 73 individuals per 100,000 of the population in the United States, while the prevalence in Japan, China, and India is around 36 to 125 per 100,000 individuals, as of 2021. Moreover, improvement in the diagnostic technologies, penetration of AI in medical diagnostics, and rising awareness amongst people regarding tests and diagnosis are anticipated to boost the market growth. Furthermore, the increasing healthcare expenditure across the globe, is forecasted to encourage the growth of the market.